These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 30524168)

  • 21. [Schizophrenia and/or bipolar disorder: the neurocognitive endophenotypes].
    Kaladjian A; Azorin JM; Pomietto P; Corréard N; Belzeaux R; Adida M
    Encephale; 2012 Dec; 38 Suppl 3():S81-4. PubMed ID: 23279993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence.
    Smeland OB; Bahrami S; Frei O; Shadrin A; O'Connell K; Savage J; Watanabe K; Krull F; Bettella F; Steen NE; Ueland T; Posthuma D; Djurovic S; Dale AM; Andreassen OA
    Mol Psychiatry; 2020 Apr; 25(4):844-853. PubMed ID: 30610197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurocognitive endophenotypes in schizophrenia and bipolar disorder: A systematic review of longitudinal family studies.
    Luperdi SC; Tabarés-Seisdedos R; Livianos L; Vieta E; Cuesta MJ; Balanzá-Martínez V
    Schizophr Res; 2019 Aug; 210():21-29. PubMed ID: 31272906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of neurocognitive function in euthymic bipolar patients and stabilized schizophrenic patients.
    Sánchez-Morla EM; Barabash A; Martínez-Vizcaíno V; Tabarés-Seisdedos R; Balanzá-Martínez V; Cabranes-Díaz JA; Baca-Baldomero E; Gómez JL
    Psychiatry Res; 2009 Oct; 169(3):220-8. PubMed ID: 19758705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive dysfunction is worse among pediatric patients with bipolar disorder Type I than Type II.
    Schenkel LS; West AE; Jacobs R; Sweeney JA; Pavuluri MN
    J Child Psychol Psychiatry; 2012 Jul; 53(7):775-81. PubMed ID: 22339488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TP53 Polymorphism Contributes to the Susceptibility to Bipolar Disorder but Not to Schizophrenia in the Chinese Han Population.
    Yang J; Wu X; Huang J; Chen Z; Huang G; Guo X; Zhu L; Su L
    J Mol Neurosci; 2019 Aug; 68(4):679-687. PubMed ID: 31055723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association study of dopamine receptor genes polymorphism with cognitive functions in bipolar I disorder patients.
    Zhao L; Lin Y; Lao G; Wang Y; Guan L; Wei J; Yang Z; Ni P; Li X; Jiang Z; Li T; Hao X; Lin D; Cao L; Ma X
    J Affect Disord; 2015 Jan; 170():85-90. PubMed ID: 25233244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant cognition in newly diagnosed patients with bipolar disorder and their unaffected relatives.
    Kjærstad HL; Mistarz N; Coello K; Stanislaus S; Melbye SA; Harmer CJ; Vinberg M; Miskowiak K; Kessing LV
    Psychol Med; 2020 Aug; 50(11):1808-1819. PubMed ID: 31456531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of shared risk loci and pathways for bipolar disorder and schizophrenia.
    Forstner AJ; Hecker J; Hofmann A; Maaser A; Reinbold CS; Mühleisen TW; Leber M; Strohmaier J; Degenhardt F; Treutlein J; Mattheisen M; Schumacher J; Streit F; Meier S; Herms S; Hoffmann P; Lacour A; Witt SH; Reif A; Müller-Myhsok B; Lucae S; Maier W; Schwarz M; Vedder H; Kammerer-Ciernioch J; Pfennig A; Bauer M; Hautzinger M; Moebus S; Schenk LM; Fischer SB; Sivalingam S; Czerski PM; Hauser J; Lissowska J; Szeszenia-Dabrowska N; Brennan P; McKay JD; Wright A; Mitchell PB; Fullerton JM; Schofield PR; Montgomery GW; Medland SE; Gordon SD; Martin NG; Krasnov V; Chuchalin A; Babadjanova G; Pantelejeva G; Abramova LI; Tiganov AS; Polonikov A; Khusnutdinova E; Alda M; Cruceanu C; Rouleau GA; Turecki G; Laprise C; Rivas F; Mayoral F; Kogevinas M; Grigoroiu-Serbanescu M; Becker T; Schulze TG; Rietschel M; Cichon S; Fier H; Nöthen MM
    PLoS One; 2017; 12(2):e0171595. PubMed ID: 28166306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphoinositide-3-kinase regulatory subunit 1 gene polymorphisms are associated with schizophrenia and bipolar disorder in the Han Chinese population.
    Huang J; Chen Z; Zhu L; Wu X; Guo X; Yang J; Long J; Su L
    Metab Brain Dis; 2020 Jun; 35(5):785-792. PubMed ID: 32193760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebellar dysconnectivity in schizophrenia and bipolar disorder is associated with cognitive and clinical variables.
    Cattarinussi G; Di Giorgio A; Sambataro F
    Schizophr Res; 2024 May; 267():497-506. PubMed ID: 38582653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between genetic risk scoring for schizophrenia and bipolar disorder with regional subcortical volumes.
    Caseras X; Tansey KE; Foley S; Linden D
    Transl Psychiatry; 2015 Dec; 5(12):e692. PubMed ID: 26645627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of a microRNA MIR137 susceptibility variant on brain function in people at high genetic risk of schizophrenia or bipolar disorder.
    Whalley HC; Papmeyer M; Romaniuk L; Sprooten E; Johnstone EC; Hall J; Lawrie SM; Evans KL; Blumberg HP; Sussmann JE; McIntosh AM
    Neuropsychopharmacology; 2012 Nov; 37(12):2720-9. PubMed ID: 22850735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The trajectory of emotional and non-emotional cognitive function in newly diagnosed patients with bipolar disorder and their unaffected relatives: A 16-month follow-up study.
    Kjærstad HL; Søhol K; Vinberg M; Kessing LV; Miskowiak KW
    Eur Neuropsychopharmacol; 2023 Feb; 67():4-21. PubMed ID: 36462414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome-wide analysis reveals genetic overlap between alcohol use behaviours, schizophrenia and bipolar disorder and identifies novel shared risk loci.
    Wiström ED; O'Connell KS; Karadag N; Bahrami S; Hindley GFL; Lin A; Cheng W; Steen NE; Shadrin A; Frei O; Djurovic S; Dale AM; Andreassen OA; Smeland OB
    Addiction; 2022 Mar; 117(3):600-610. PubMed ID: 34472679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Manual motor speed dysfunction as a neurocognitive endophenotype in euthymic bipolar disorder patients and their healthy relatives. Evidence from a 5-year follow-up study.
    Correa-Ghisays P; Balanzá-Martínez V; Selva-Vera G; Vila-Francés J; Soria-Olivas E; Vivas-Lalinde J; San Martín C; Borrás AM; Ayesa-Arriola R; Sanchez-Moreno J; Sánchez-Ort J; Crespo-Facorro B; Vieta E; Tabarés-Seisdedos R
    J Affect Disord; 2017 Jun; 215():156-162. PubMed ID: 28334676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder.
    Bergen SE; O'Dushlaine CT; Ripke S; Lee PH; Ruderfer DM; Akterin S; Moran JL; Chambert KD; Handsaker RE; Backlund L; Ösby U; McCarroll S; Landen M; Scolnick EM; Magnusson PK; Lichtenstein P; Hultman CM; Purcell SM; Sklar P; Sullivan PF
    Mol Psychiatry; 2012 Sep; 17(9):880-6. PubMed ID: 22688191
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive deficits in first-degree relatives of bipolar patients: the use of homogeneous subgroups in the search of cognitive endophenotypes.
    Volkert J; Haubner J; Kazmaier J; Glaser F; Kopf J; Kittel-Schneider S; Reif A
    J Neural Transm (Vienna); 2016 Aug; 123(8):1001-11. PubMed ID: 27273092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perceived stress and hair cortisol: Differences in bipolar disorder and schizophrenia.
    Streit F; Memic A; Hasandedić L; Rietschel L; Frank J; Lang M; Witt SH; Forstner AJ; Degenhardt F; Wüst S; Nöthen MM; Kirschbaum C; Strohmaier J; Oruc L; Rietschel M
    Psychoneuroendocrinology; 2016 Jul; 69():26-34. PubMed ID: 27017430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurocognitive Impairments (NCI) in bipolar disorder: Comparison with schizophrenia and healthy controls.
    Esan O; Oladele O; Adediran KI; Abiona TO
    J Affect Disord; 2020 Dec; 277():175-181. PubMed ID: 32829193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.